{"id":6129,"date":"2022-06-14T15:05:00","date_gmt":"2022-06-14T15:05:00","guid":{"rendered":"https:\/\/realheart.se\/mfn_news\/realhearts-ceo-in-filmed-company-presentation-the-biggest-news-for-2022-is-that-the-clinical-version-of-realheart-tah-is-fully-developed-and-under-production\/"},"modified":"2022-06-14T15:05:00","modified_gmt":"2022-06-14T15:05:00","slug":"realhearts-ceo-in-filmed-company-presentation-the-biggest-news-for-2022-is-that-the-clinical-version-of-realheart-tah-is-fully-developed-and-under-production","status":"publish","type":"mfn_news","link":"https:\/\/realheart.se\/sv\/mfn_news\/realhearts-ceo-in-filmed-company-presentation-the-biggest-news-for-2022-is-that-the-clinical-version-of-realheart-tah-is-fully-developed-and-under-production\/","title":{"rendered":"Realheart&#8217;s CEO in Filmed Company Presentation: &#8221;the biggest news for 2022 is that the clinical version of Realheart\u00ae TAH is fully developed and under production&#8221;"},"content":{"rendered":"<p><span><span>In a filmed presentation on the occasion of Realheart&#39;s Annual General Meeting, CEO Ina Laura Perkins describes what the company has done during the past year and what is in the pipeline for 2022.<\/span><\/span><\/p>\n<p><span><span>Among other things, Ina Laura explains what the four key factors for success are and why the Company has started a subsidiary in Australia.<\/span><\/span><\/p>\n<p><span><span>Link to the Filmed Presentation:\u00a0<\/span><\/span><span><a href=\"https:\/\/youtu.be\/DQAErlgdRBE\" rel=\"nofollow\">https:\/\/youtu.be\/DQAErlgdRBE<\/a><\/span><\/p>\n<div class=\"mfn-footer\">\n<p><span><strong><span><span>For more information please contact:<\/span><\/span><\/strong><\/span><\/p>\n<p><span><span>Ina Laura Perkins, CEO<\/span><\/span><\/p>\n<p><span><span>Phone: +46(0)70 406 49 21\u00a0<\/span><\/span><\/p>\n<p><span><span>E-mail: inalaura.perkins@realheart.se<\/span><\/span><\/p>\n<p>Certified Adviser: Svensk Kapitalmarknadsgranskning AB, Phone: +46 11 32 30\u00a0732, email:\u00a0<a href=\"mailto:ca@skmg.se\" rel=\"nofollow\">ca@skmg.se<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about\">\n<p><span><span><em>Scandinavian Real Heart AB develops a total artificial heart (TAH) for implantation in patients with life-threatening heart failure. Realheart<\/em><\/span><\/span><em><span><span><span>\u00ae<\/span><\/span><\/span><\/em><span><span><em> TAH has a unique, patented design that resembles that of the natural human heart. The artificial heart consists of a four-chamber system (two atria and two ventricles) designed to generate a physiological blood flow pattern that mimics the body&#39;s natural circulation.\u00a0<\/em><\/span><\/span><em><span><span><span>A unique concept in the medical technology world.<\/span><\/span><\/span><\/em><\/p>\n<\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><div class=\"mfn-attachment\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/proxy\/realhearts-ceo-in-filmed-company-presentation-the-biggest-news-for-2022-is-that-the-clinical-version-of-realheart-tah-is-fully-developed-and-under-production.pdf?url=https%3A%2F%2Fmb.cision.com%2FMain%2F12118%2F3585431%2F1592771.pdf\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/proxy\/realhearts-ceo-in-filmed-company-presentation-the-biggest-news-for-2022-is-that-the-clinical-version-of-realheart-tah-is-fully-developed-and-under-production.pdf?url=https%3A%2F%2Fmb.cision.com%2FMain%2F12118%2F3585431%2F1592771.pdf&type=jpg\"><\/span>Realheart's CEO in Filmed Company Presentation: \"the biggest news for 2022 is that the clinical version of Realheart\u00ae TAH is fully developed and under production\"<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>In a filmed presentation on the occasion of Realheart&#39;s Annual General Meeting, CEO Ina Laura Perkins describes what the company has done during the past year and what is in the pipeline for 2022. Among other things, Ina Laura explains what the four key factors for success are and why the Company has started a&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-6129","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn","mfn-news-tag-mfn-ci-other"],"acf":[],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Realheart&#039;s CEO in Filmed Company Presentation: &quot;the biggest news for 2022 is that the clinical version of Realheart\u00ae TAH is fully developed and under production&quot; - Realheart<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/realheart.se\/mfn_news\/realhearts-ceo-in-filmed-company-presentation-the-biggest-news-for-2022-is-that-the-clinical-version-of-realheart-tah-is-fully-developed-and-under-production\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Realheart&#039;s CEO in Filmed Company Presentation: &quot;the biggest news for 2022 is that the clinical version of Realheart\u00ae TAH is fully developed and under production&quot; - Realheart\" \/>\n<meta property=\"og:description\" content=\"In a filmed presentation on the occasion of Realheart&#039;s Annual General Meeting, CEO Ina Laura Perkins describes what the company has done during the past year and what is in the pipeline for 2022. Among other things, Ina Laura explains what the four key factors for success are and why the Company has started a...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/realheart.se\/mfn_news\/realhearts-ceo-in-filmed-company-presentation-the-biggest-news-for-2022-is-that-the-clinical-version-of-realheart-tah-is-fully-developed-and-under-production\/\" \/>\n<meta property=\"og:site_name\" content=\"Realheart\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realhearts-ceo-in-filmed-company-presentation-the-biggest-news-for-2022-is-that-the-clinical-version-of-realheart-tah-is-fully-developed-and-under-production\\\/\",\"url\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realhearts-ceo-in-filmed-company-presentation-the-biggest-news-for-2022-is-that-the-clinical-version-of-realheart-tah-is-fully-developed-and-under-production\\\/\",\"name\":\"Realheart's CEO in Filmed Company Presentation: \\\"the biggest news for 2022 is that the clinical version of Realheart\u00ae TAH is fully developed and under production\\\" - Realheart\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\"},\"datePublished\":\"2022-06-14T15:05:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realhearts-ceo-in-filmed-company-presentation-the-biggest-news-for-2022-is-that-the-clinical-version-of-realheart-tah-is-fully-developed-and-under-production\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realhearts-ceo-in-filmed-company-presentation-the-biggest-news-for-2022-is-that-the-clinical-version-of-realheart-tah-is-fully-developed-and-under-production\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realhearts-ceo-in-filmed-company-presentation-the-biggest-news-for-2022-is-that-the-clinical-version-of-realheart-tah-is-fully-developed-and-under-production\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Realheart&#8217;s CEO in Filmed Company Presentation: &#8220;the biggest news for 2022 is that the clinical version of Realheart\u00ae TAH is fully developed and under production&#8221;\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\",\"url\":\"https:\\\/\\\/realheart.se\\\/\",\"name\":\"Realheart\",\"description\":\"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/realheart.se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Realheart's CEO in Filmed Company Presentation: \"the biggest news for 2022 is that the clinical version of Realheart\u00ae TAH is fully developed and under production\" - Realheart","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/realheart.se\/mfn_news\/realhearts-ceo-in-filmed-company-presentation-the-biggest-news-for-2022-is-that-the-clinical-version-of-realheart-tah-is-fully-developed-and-under-production\/","og_locale":"sv_SE","og_type":"article","og_title":"Realheart's CEO in Filmed Company Presentation: \"the biggest news for 2022 is that the clinical version of Realheart\u00ae TAH is fully developed and under production\" - Realheart","og_description":"In a filmed presentation on the occasion of Realheart&#39;s Annual General Meeting, CEO Ina Laura Perkins describes what the company has done during the past year and what is in the pipeline for 2022. Among other things, Ina Laura explains what the four key factors for success are and why the Company has started a...","og_url":"https:\/\/realheart.se\/mfn_news\/realhearts-ceo-in-filmed-company-presentation-the-biggest-news-for-2022-is-that-the-clinical-version-of-realheart-tah-is-fully-developed-and-under-production\/","og_site_name":"Realheart","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/realheart.se\/mfn_news\/realhearts-ceo-in-filmed-company-presentation-the-biggest-news-for-2022-is-that-the-clinical-version-of-realheart-tah-is-fully-developed-and-under-production\/","url":"https:\/\/realheart.se\/mfn_news\/realhearts-ceo-in-filmed-company-presentation-the-biggest-news-for-2022-is-that-the-clinical-version-of-realheart-tah-is-fully-developed-and-under-production\/","name":"Realheart's CEO in Filmed Company Presentation: \"the biggest news for 2022 is that the clinical version of Realheart\u00ae TAH is fully developed and under production\" - Realheart","isPartOf":{"@id":"https:\/\/realheart.se\/#website"},"datePublished":"2022-06-14T15:05:00+00:00","breadcrumb":{"@id":"https:\/\/realheart.se\/mfn_news\/realhearts-ceo-in-filmed-company-presentation-the-biggest-news-for-2022-is-that-the-clinical-version-of-realheart-tah-is-fully-developed-and-under-production\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/realheart.se\/mfn_news\/realhearts-ceo-in-filmed-company-presentation-the-biggest-news-for-2022-is-that-the-clinical-version-of-realheart-tah-is-fully-developed-and-under-production\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/realheart.se\/mfn_news\/realhearts-ceo-in-filmed-company-presentation-the-biggest-news-for-2022-is-that-the-clinical-version-of-realheart-tah-is-fully-developed-and-under-production\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"MFN News Items","item":"https:\/\/realheart.se\/mfn_news\/"},{"@type":"ListItem","position":2,"name":"Realheart&#8217;s CEO in Filmed Company Presentation: &#8220;the biggest news for 2022 is that the clinical version of Realheart\u00ae TAH is fully developed and under production&#8221;"}]},{"@type":"WebSite","@id":"https:\/\/realheart.se\/#website","url":"https:\/\/realheart.se\/","name":"Realheart","description":"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/realheart.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news\/6129","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/media?parent=6129"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}